The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
Dachuan Zeng(Children's Hospital of Chongqing Medical University), Zhenglan Huang(Chongqing Medical University)
Cited by 14
Related Papers
Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus
|Oncotarget|2013|16
Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190BCR-ABL
|Cell Communication and Signaling|2023|12